Kyorin Eye Center
Mitaka, Tokyo, 181-8611, Japan
NCT Number: NCT01307072
The relationship between the surgical outcome of vitreous surgery for proliferative diabetic retinopathy and the compliance to ophthalmic follow-up examinations was evaluated.
Looking for future studies?
Notify MeAll sexes
Observational
Mitaka, Tokyo, 181-8611, Japan
The medical records of 94 patients that had undergone vitreous surgery for proliferative diabetic retinopathy (PDR) and were followed for at least 6 months were reviewed. The subjects were divided into three groups; the never-treated group consisting of patients who had no previous ophthalmic examination until the first visit when vitreous surgery was prescribed; the non-compliant group consisting of patients with a history of missing ophthalmic examination over a one year period, and the compliant group consisting of patients who had ophthalmic examinations at least once a year. The evaluations included age, gender, plasma level of glycosylated hemoglobin (HbA1c) at the preoperative examination, presence of preoperative panretinal photocoagulation, preoperative best-corrected visual acuity (BCVA), postoperative BCVA at the final examination, status of the PDR, the numbers of vitreous surgeries, and presence of pre- and postoperative neovascular glaucoma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vitrectomy. Diabetic retinopathy
Other names: Compliance of follow-up
Time frame: Preoperative period
Plasma level of glycosylated hemoglobin (HbA1c)
Time frame: Preoperative period
Best-corrected visual acuity (BCVA),
Time frame: up to 1 year
Postoperative best-corrected visual acuity (BCVA) at 6 months and the final examination
Time frame: up to 1 year
Status of the proliferative diabetic retinopathy
Time frame: up to 1 year
Presence of neovascular glaucoma.
Kyorin University
Other
Compliance to Ophthalmic Follow-up Examinations Affect Outcome of Vitrectomy for Proliferative Diabetic Retinopathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07640256
Agnosia, Nervous System Diseases
Mexico City, Mexico
View Trial DetailsNCT02879422
Proliferative Diabetic Retinopathy
Reims, France
View Trial DetailsNCT04278417
Eye Diseases, Metaplasia
Tucson, Arizona, United States
View Trial DetailsNCT07144865
Proliferative Diabetic Retinopathy
Tianjin, Tianjin Municipality, China
View Trial Details